S. Korean scientists have developed a human vaccine for H1N1.
A team of South Korean scientists, led by professor Seo Sang-Hee of Chungnam National University's College of Veterinary Medecine said on 18 May they have succeeded in developing a human vaccine against H1N1, which can be used to stem the worldwide spread of the disease.
The researchers said they have cultivated the 'standard virus' supplied by the CDC(U.S. Centers for Disease Control and Prevention) and created a material that is not toxic and can be mass produced cheaply. They also said the vaccine was developed on 15 May, 11 days after the CDC provided the virus sample.
The vaccine strain has been named CNUK-RG A/CA/4xPR/8 (H1N1).
Its effectiveness has been verified through tests conducted on human and monkey cell samples.
A fully developed vaccine should come out in the market in this September after basic clinical experiments are completed.
Professor Seo said, "Our vaccine is probably the first developed in the world. We are ready to provide the data to make the treatment material available to pharmaceutical companies and research laboratories around the world free of charge."
Last year, professor Seo Sang-Hee succeeded in creating a vaccine for bird flu. <헬스코리아뉴스>